Crouzon's syndrome: Differential in vitro secretion of bFGF, tgfβ isoforms and extracellular matrix macromolecules in patients with FGFR2 gene mutation

Cytokine

Volumn 19, Issue 2, 2002, Pages 94-101

  Baroni, Tiziano ^a   Lilli, Cinzia ^a   Marinucci, Lorella ^a   Bellocchio, Silvia ^a   Pezzetti, Furio ^b   Carinci, Francesco ^c   Stabellini, Giordano ^d   Balducci, Chiara ^a   Locci, Paola ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

bFGF; Crouzon's syndrome; ECM FGFR2 mutation; TGF 1

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBRONECTIN; GLYCOSAMINOGLYCAN; ISOPROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CELL LEVEL; CONTROLLED STUDY; CROUZON SYNDROME; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MACROMOLECULE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

EID: 0036382754     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.0877     Document Type: Article

References (68)

1. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcom S (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genetics 8:98-103.
2. Kolar JC, Munrho IR, Farkas LG (1988) Pattern of dysmorphology in Crouzon syndrome: an anthropometric study. Cleft Palate J 25:235-244.
3. Carinci F, Avantaggiato A, Curioni C (1994) Crouzon syndrome: Cephalometric analysis and evaluation of pathogenesis. Cleft Palate-Cran J 31(3):201-209.
4. Muenke M, Schell U (1991) Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11:308-313.
5. Naski MC, Ornitz DM (1998) FGF signaling in skeletal development. Front Biosci 3:781-794.
6. Tartaglia M, Di Rocco C, Lajeunie E, Valeri S, Velardi F, Battaglia PA (1997) Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders. Hum Genet 101:47-50.
7. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AOM (1995) Identical mutations in the FGFR2 gege cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Gen 9:173-176.
8. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcom S, Winter RM, Reardon W (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 9:165-172.
9. Wilkie AOM, Wall SA (1996) Craniosynostosis: novel insights into pathogenesis and treatment. Dev Disorders 9:146-152.
10. Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ (1998) Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 95:4567-4572.
11. Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
12. Givol D, Yayon A (1992) Complexity of FGF receptors: genetic basic for structural diversity and functional specificity. FASEB J 6:3362-3369.
13. Bodo M, Baroni T, Carinci F, Becchetti E, Bellucci C, Conte C, Pezzetti F, Evangelisti R, Tognon M, Carinci P (1999) A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome. Eur J Cell Biol 78:323-330.
14. Gospodarowicz D, Ferrara L, Schweigerer L, Neufeld F (1987) Structural characterization and biological functions of fibroblast growth factors. Endocr Rev 8:95-114.
15. Olwin BB, Hauschka SD (1990) Fibroblast growth factor receptor levels decrease during chick embryogenesis. J Cell Biol 110:503-509.
16. Frenz DA, Liu W, Williams JD, Hatcher V, Galinovic-Schwartz V, Flanders KC, Van De Water TR (1994) Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120:415-424.
17. Hurley MM, Abreu C, Gronowicz G, Kawaguchi H, Lorenzo J (1994) Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J Biol Chem 269(12):9392-9396.
18. Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes and Dev 8:133-146.
19. 1 transforming growth factor gene expression in osteoblasts-like cells. J Cell Biol 109:2529-2535.
20. Pelton RW, Hogan BL, Miller DA, Moses HL (1990) Differential expression of genes encoding TGFs b1, b2 and b3 during murine palatal formation. Dev Biol 141:456-460.
21. 1 is an epithelial-derived signal peptide that influences otic capsule formation. Dev Biol 153:324-336.
22. Kato Y (1992) Roles of fibroblast growth factor and transforming growth factor-β families in cartilage formation. In: Adolphe M (ed.) Biological Regulation of the Chondrocytes. CRC Press, Boca Raton, pp 141-160.
23. Canalis E, McCarthy TL, Centrella M (1989) The role of growth factors in skeletal remodeling. Metab Bone Dis 4:903-918.
24. Centrella M, Horowitz MC, Wozney JM, McCarthy TL (1994) Transforming growth factor-β gene family members and bone. Endocr Rev 15:27-39.
25. 1 in Apert osteoblasts. Cell Tissue Res 297:475-483.
26. Stein GS, Lian JB, Owen TA (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111-3123.
27. Schmid P, Cox D, Bilbe G, Maier R, McMaster GK (1991) Differential expression of TGFβ1, β2 and β3 genes during mouse embryogenesis. Development 11:117-130.
28. Kirk MD, Kahn AJ (1995) Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta1 in osteoblast cell-matrix interaction. J Bone Miner Res 10(8):1203-1208.
29. Becchetti E, Evangelisti R, Stabellini G, Pagliarini A, Del Borrello E, Calastrini C, Carinci P (1988) Developmental heterogeneity of mesenchymal glycosaminoglycans (GAG) distribution in chick embryo lung anlagen. Am J Anat 81:33-42.
30. Carinci P, Locci P, Evangelisti R, Marinucci L, Rossi L, Becchetti E (1991) Relation between hyaluronan and sulphated glycosaminoglycan synthesis and degradation in culture embryonic fibroblasts. Effect of Concanavalin A and ammonium chloride administration. Cell Biochem Funct 9:255-262.
31. Adams JC, Watt FM (1993) Regulation of development and differentiation by the extracellular matrix. Development 117:1183-1198.
32. Locci P, Lilli C, Marinucci L, Baroni T, Pezzetti F, Becchetti E (1993) Embryonic skin fibroblasts release TGFα and TGFβ able to influence synthesis and secretion of GAG. Cell Mol Biol 39:415-426.
33. Bodo M, Becchetti E, Giammarioli M, Baroni T, Bellucci C, Pezzetti F, Calvitti M, Carinci P (1994) Interleukin 1 and interleukin 6 differentially regulate the accumulation newly synthesizes extracellular matrix components and the cytokine release by developing chick embryo skin fibroblasts. Int J Dev Biol 38:535-542.
34. Martins-Green M, Bissell MJ (1995) Cell-ECM interactions in development. Dev Biol 6:149-159.
35. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113:981-986.
36. Locci P, Marinucci L, Lilli C, Martinese D, Becchetti E (1995) Transforming growth factor β1-hyaluronic acid interaction. Cell Tissue Res 281:317-324.
37. Davidson JM, Zoia O, Liu JM (1993) Modulation of transforming growth factor beta 1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor alfa and insulin-like growth factor-I. J Cell Physiol 155:149-156.
38. Gorry MC, Preston RA, White GJ, Zhang Y, Singhal VK, Losken HW, Parker MG, Nwokoro NA, Post JC, Ehrlich GD (1995) Crouzon syndrome: mutations in two splice forms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 4:1387-1390.
39. Steinberger D, Mulliken JB, Muller U (1995) Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum Genet 96(1):113-115.
40. Wilkie AOM (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6(10):1647-1656.
41. Mangasarian K, Li Y, Mansukhani A, Basilico C (1997) Mutation associated with Crouzon syndrome causes ligand independent dimerization and activation of FGF receptor-2. J Cell Physiol 172(1):117-125.
42. Huang CC (1987) Bone resorption in experimental otosclerosis in rats. Am J Otoralyngol 8:332-341.
43. Ribari O, Pereplica M, Sziklai I (1991) Oversulphated mucopolysaccharides in the otosclerotic bone. Acta Otolaryngol 111:362-365.
44. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DN (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
45. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ (1994) Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell artheritis. Ann Intern Med 121:484-491.
46. Assoian RK, Fleurdeleys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB (1987) Expression and secretion of TGFβ by activated human macrophages. Proc Acad Sci USA 84:6020-6024.
47. 3 and insulin-like growth factor 1 in premature cranial suture fusion. Plast Reconstr Surg 99:300-309.
48. Bonewald LF (1999) Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukar Gene Exp 9(1): 33-44.
49. Gajdusek CM, Lou Z, Mayberg MR (1993) Basic fibroblast growth factor and transforming growth factor beta-1: Synergistic mediators of angiogenesis in vitro. J Cell Physiol 157:133-144.
50. Smith GM, Hale JH (1997) Macrophages/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-β and basic fibroblast growth factor. J Neurosci 17(24):9624-9633.
51. Bodo M, Carinci F, Baroni T, Becchetti E, Giammarioli M, Bellucci C, Pezzetti F, Evangelisti R, Carinci P (1996) Effects of interleukins on Crouzon fibroblast phenotype in vitro. Release of cytokines and IL-6 mRNA expression. Cytokine 8(10):772-783.
52. Bodo M, Baroni T, Carinci F, Becchetti E, Conte C, Bellucci C, Pezzetti F, Calvitti M, Bellocchio S, Stabellini G, Carinci P (1999) Interleukin secretion, proteoglycan and procollagen a1 (1) gene expression in Crouzon fibroblasts treated with basic fibroblast growth factor. Cytokine 12:1280-1283.
53. Roodman GD, Kurihara N, Kukita A, Hosting D, Demulder A, Smith JF, Singer FR (1992) Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89:46-52.
54. Locci P, Becchetti E, Venti G, Lilli C, Marinucci L, Donti E, Paludetti G, Maurizi M (1996) Glycosaminoglycan metabolism in otosclerotic bone cells. Biol Cell 86:73-78.
55. Moscatelli D (1994) Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cells. J Cell Physiol 160:555-562.
56. Yayon A, Klagsbrun M (1990) Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal of suramin. Proc Natl Acad Sci USA 87:5346-5350.
57. Lomri A, Lemmonier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ (1998) Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 101:1310-1317.
58. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB (1992) Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J Cell Biol 118:901-909.
59. Villeger PM, Lotz M (1992) Differential expression of TGF-beta isoforms by human articular chondrocytes in response to growth factor. J Cell Physiol 151:318-325.
60. Phillips AO, Topley N, Morrisey K, Williams JD, Steadman R (1997) Basic fibroblast growth factor stimulates the release of preformed transforming growth factor β1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation. Lab Invest 76(4):591-600.
61. Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM, Twigg SR, Johnson D, Wall SA, Jiang W, Theda C, Jabs EW, Wilkie AO (1999) De novo alu-element insertions in FGFR2 identify pathological basis for Apert syndrome. Am J Hum Genet 64:446-461.
62. Locci P, Evangelisti R, Lilli C, Stabellini G, Becchetti E, Carinci P (1992) An evaluation of the mechanisms developmentally involved on cellular and extracellular glycosaminoglycans accumulation in chick embryo skin fibroblasts. Int J Biochem 24:151-158.
63. Webster DF, Harvey WA (1979) A quantitative assay for collagen synthesis in microwell fibroblast cultures. Anal Biochem 96:220-224.
64. Engvall E, Ruoslahti E (1977) Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20:1-5.
65. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
66. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV (1985) Human transforming growth factor β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705.
67. Meager A (1991) Assays for transforming growth factor β. J Immunol Methods 141:1-14.
68. Lowry OH, Rosebrough NJ, Farr AJ, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.